Apoptosis(2012)17:248–257membersoftheglucoseregulatedprotein(GRP)family78and94,andthesechaperonesprotectthecellagainstERstress.ATF6isabasicleucinezippertranscriptionfactor,whichisknowntobeessentialforXBP1mRNAexpres-sionandchaperoneinductionunderERstressconditions[3–5].
DuringUPR,theaccumulatedmisfolded/unfoldedpro-teiniseithercorrectlyrefoldedorissubjecttoproteindegradationbytheubiquitin–proteasomepathway.How-ever,whencellsareunabletorestorehomeostasisastheresultsofprolongedERstress,apoptosisistriggeredinthedamagedcells[6,7].ThebestcharacterizedmediatorinthetransitionofERstresstoapoptosisisatranscriptionfactorcalledC/EBPhomologousprotein(CHOP),whichislocateddownstreamofATF4andATF6[3].InadditiontoCHOP,theactiveIRE1leadstoapoptosisbystimulatingthephosphorylationofmitogen-activatedproteinkinase(MAPK)upontheimpositionofERstress[8,9].
Asaresult,pharmacologicalintervention,whichiscapableofinducingprolongedERstress,hasbeenrecentlyproposedasapossiblemethodforenhancingcancerther-apy[10–13].Takingthisintoconsideration,wehavescreenedandevaluatedthepharmacologicaleffectsofanumberofnaturalcompounds,andreporthereinthatcryptotanshinoneinducesERstressinmanycancercells,includingHepG2hepatomaandMCF7breastcancercells;thisERstresseventuallyleadstoapoptosis.Cryptotanshi-none,amajortanshinoneisolatedfromSalviamiltiorrhiza,evidencesmultipleactivities,includinganti-bacterial,anti-in ammatory,anti-obesity,andanti-diabeticactivity[14,15].Recently,theanti-canceractivityofcryptotan-shinonehasalsobeenreported[16–22],buttheprecisemolecularmechanismsunderlyingtheseactivitiesremaintobeclearlyelucidated.
Inthisstudy,forthe rsttime,wehaveidenti edthenovelmolecularmechanismunderlyingtheanti-canceractivityofcryptotanshinone;speci cally,itwasshowntoinduceERstress-mediatedapoptosisinHepG2andMCF7cancercellsviareactiveoxygenspecies(ROS)generation.Additionally,wealsonotedthatcombinedtreatmentwithdiverseanti-canceragentsandcryptotanshinonemarkedlyincreasedthesensitivityofHepG2andMCF7cellstoapoptosisviatheinductionofERstress.Thesedatasupportthenotionthatcryptotanshinonecouldbeusedtodevelopanovelcancerchemotherapeuticmodality.
MaterialsandmethodsCelllines
HepG2(humanhepatomacarcinoma)cellswereincubatedinDulbecco’smodi edEagle’smedium(DMEM),and
249
AGS(humangastriccarcinoma),HeLa(humancervicalcarcinoma),MCF7(humanbreastcarcinoma),A549(humanlungcarcinoma),Jurkat(humanTleukemiacar-cinoma)andU937(humanleukemiacarcinoma)cellsweremaintainedinRPMImedium1640.Allcellsamplesweresupplementedwith10%heat-inactivatedFBSandantibi-oticsat37°Cwith95%airand5%CO2.Reagents
Theanti-caspase-3antibodiesandtheanti-phospho-speci cantibodiesthatrecognizethephosphoactivatedformsofp42/44MAPK-Thr202/Tyr204,SAPK/JNK-Thr183/Tyr185,p38MAPK-Thr180/Tyr182,MEK1/2-Ser217/221,MKK3/MKK6-Ser189/207,SEK1/MKK4-Thr261andtheantibodiesagainstSAPK/JNK,p42/44,p38,MEK1/2,MKK3/MKK6,SEK1/MKK4werepurchasedfromCellSignalingTechnology(Beverly,MA).Theanti-phospho-eIF2a(Ser-51)andanti-C/EBP-homologousprotein(CHOP)werealsopurchasedfromCellSignalingTechnol-ogy.TheantibodiesagainstPARP,actin,anda-actininwerepurchasedfromSantaCruzBiotechnology(SantaCruz,CA).Theantibodiesagainstglucose-regulatedprotein(GRP)94andGRP78werepurchasedfromAbcam(Cam-bridge,UK).ThegeneralERstressinducersthapsigargin(Tg)andtunicamycin(Tm)wereobtainedfromBIOMOLandutilizedat1lMand10lg/ml,respectively.PD98059(Catalogno.1213),SP600125(Catalogno.1496)andSB203580(Catalogno.1202)werefromTOCRIS(Bristol,UK).Fas-activatingmouseanti-FasIgM(cloneCH11)wasobtainedfromUpstateBiotechnology(Waltham,MA).5-FU,cisplatin,etoposide,N-acetylcysteine(NAC),4-phe-nylbutyricacid(4-PBA)andpropidiumiodidewereobtainedfromSigma-Aldrich(St.Louis,MO),andTNF-awaspurchasedfromInvitrogen(Carlsbad,CA).SalubrinalwaspurchasedfromCalbiochem(Darmstadt,Germany).Isolationofcryptotanshinone
CryptotanshinonewasisolatedfromthedriedrootsofS.miltiorrhizaviaanidenticalfractionationprotocol,aspreviouslydescribed[23].DriedrootsofS.miltiorrhiza(11kg)wereextractedwithCH2Cl2atroomtemperaturefor7daysandthesolventwasevaporatedtoobtainthecrudeextract(93.11g).CH2Cl2extract(90g)wasappliedtothesilicagelcolumnchromatographyelutedbyn-hex-ane–EtOAcmixtureandCH2Cl2–EtOAcinmobilephasetoobtainsixfractions(SMC1-6),basedontheTLCpat-tern.Accordingtothebioactivity-guidedfractionmethod,SMC-5fraction(13.7g)wasrechromatographedoverasilicagelcolumnusingahexane–CH2Cl2mixture(5:1,3:1,1:1,1:3,successively)toobtain vefractions(SMC5A-5E).Then,theSMC5Efraction(2.3g)wasseparatedusing
123
热门文档